Oak Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,303
Closed -$512K 99
2022
Q3
$512K Buy
+8,303
New +$524K 0.25% 67
2022
Q2
Sell
-10,049
Closed -$597K 108
2022
Q1
$597K Sell
10,049
-50
-0.5% -$3.2K 0.24% 68
2021
Q4
$733K Sell
10,099
-6,876
-41% -$474K 0.28% 63
2021
Q3
$1.12M Sell
16,975
-291
-2% -$20.4K 0.47% 55
2021
Q2
$1.19M Sell
17,266
-70
-0.4% -$4.67K 0.5% 52
2021
Q1
$1.12M Sell
17,336
-5
-0% -$322 0.6% 42
2020
Q4
$1.01M Sell
17,341
-744
-4% -$44.9K 0.49% 51
2020
Q3
$1.1M Sell
18,085
-84
-0.5% -$5.83K 0.58% 47
2020
Q2
$1.4M Sell
18,169
-12
-0.1% -$920 0.83% 42
2020
Q1
$1.36M Sell
18,181
-197
-1% -$13.6K 0.99% 36
2019
Q4
$1.19M Sell
18,378
-925
-5% -$60.2K 0.66% 47
2019
Q3
$1.22M Buy
19,303
+47
+0.2% +$3.07K 0.74% 46
2019
Q2
$1.25M Buy
19,256
+489
+3% +$32.2K 0.78% 44
2019
Q1
$1.22M Sell
18,767
-307
-2% -$20.4K 0.81% 42
2018
Q4
$1.19M Sell
19,074
-1,029
-5% -$71.9K 0.88% 38
2018
Q3
$1.55M Sell
20,103
-115
-0.6% -$8.69K 0.94% 35
2018
Q2
$1.43M Sell
20,218
-714
-3% -$50.4K 0.98% 35
2018
Q1
$1.58M Sell
20,932
-52
-0.2% -$4.13K 1.22% 27
2017
Q4
$1.5M Buy
+20,984
New +$1.59M 1.14% 28

Other funds holding GILD

Oak Asset Management's GILD Position: Q4 2022 in Review

Oak Asset Management sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 8,303 shares — an estimated $512K sold.

Oak Asset Management first reported a position in GILD in Q4 2017 and held it in 19 quarters. The position peaked at $1.58M in Q1 2018. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Oak Asset Management reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Oak Asset Management sold 8,303 Gilead Sciences shares in Q4 2022, an estimated $512K.
  • Oak Asset Management first reported a position in Gilead Sciences in Q4 2017 and held it in 19 quarters.
  • Oak Asset Management's Gilead Sciences position peaked at $1.58M in Q1 2018.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Oak Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.